Financial Post
🏢 Postmedia
📍 ON
Jun 10, 2026
· 2 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Apotex, Backers Raise $932 Million in Canada IPO Priced at Top
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg 0.005
1,002 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Article content (Bloomberg) — Apotex Health Corp. and some of its backers raised C$1.3 billion ($932 million) in a Toronto initial public offering, the country’s largest since 2021. Article content The Canadian generic drug manufacturer priced its IPO at C$24 per share, the high end of the C$20 to C$24 range, according to a statement Tuesday confirming an earlier Bloomberg News report. Apotex sold 35.4 million shares and the selling holders divested about 18.8 million shares, after increasing the number of shares in the offering on Monday. Article content Article content Article content The IP…
Read full article at Financial Post ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jun 10, 2026